Major shareholder announcement - Invesco Ltd.
ANNOUNCEMENT NO. 251
Major shareholder announcement
Major shareholder announcement – Invesco Ltd.
Pursuant to Section 38 of the Danish Capital Markets Act, it is hereby announced that Invesco Ltd. has informed ChemoMetec A/S that on 29 February 2024, Invesco Ltd. decreased its holding of voting rights to below 5% of the total voting rights in ChemoMetec A/S.
Additional information
Niels Høy Nielsen, CFO
Telephone (+45) 2551 8724
About ChemoMetec A/S
ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec’s instruments are marketed to the pharmaceutical, biotech and agricultural industries worldwide. ChemoMetec’s customers include some of the world’s leading pharmaceutical companies, such as Novartis, Novo Nordisk, H. Lundbeck, Merck, AstraZeneca and Johnson & Johnson.
ChemoMetec was founded in 1997 and is listed on Nasdaq OMX Copenhagen. For more information, go to www.chemometec.com
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
- Picard Medical Reports Second Quarter 2026 Financial Results
- Banijay Group: Special shares adjustments
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share